Search results
Showing 511 to 525 of 973 results for death
especially morphine, can be negatively associated with adverse effects and death. To improve adherence and to enable patients and carers...
is also limited information on the risk of pregnancy (including cardiac death) in a woman with FH. Data on the incidence of cardiac...
too narrow will delay the emergency treatment of infection and may lead to death, increased need for intensive or critical care...
after birth.There is little evidence on the experience families have of the death of a baby with or without specific support from a...
Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy.
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders (TA748)
Evidence-based recommendations on mexiletine (Namuscla) for treating the symptoms of myotonia in adults with non-dystrophic myotonic disorders.
Evidence-based recommendations on vandetanib (Caprelsa) for treating medullary thyroid cancer in adults.
Tildrakizumab for treating moderate to severe plaque psoriasis (TA575)
Evidence-based recommendations on tildrakizumab (Ilumetri) for treating moderate to severe plaque psoriasis in adults.
tests to identify whether they have a higher risk profile for early cardiac death, which could be reduced by revascularisation. This...
multidisciplinary orcomplex care needs, and recognising a person's preferred place of death in palliative care. In many locations around...
being more aware of the likely progression and prepare themselves for the death of their loved one.Accurate predictions of survival...
the person's place of residence, such as a nursing home, especially when death is imminent. Such discharges are often delayed because of...
coagulopathy could reduce mortality from haemorrhage, which is the main cause of death in patients with major trauma. Point-of-care...
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)
Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events after myocardial infarction in adults.
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)
This guideline covers identifying and assessing risk of cardiovascular disease (CVD) in adults without established CVD. It covers lifestyle changes and lipid-lowering treatment (including statins) for primary and secondary prevention of CVD, and includes guidance for people who also have diabetes or chronic kidney disease.